comparemela.com

Latest Breaking News On - Biopharmaceuticals - Page 1 : comparemela.com

Exclusive | Made in China 2025: China meets most targets in manufacturing plan, proving US tariffs and sanctions ineffective

Almost 10 years after the ‘Made in China 2025’ targets were drawn up, we investigate just how many have been achieved.

France
Beidou
Anhui
China
Germany
Japan
United-states
Chinese
American
Joe-biden
Zang-jiyuan
Janet-yellen

Lyophilization Services for Biopharmaceuticals Global

Dublin, April 09, 2024 (GLOBE NEWSWIRE) The

Japan
China
South-korea
Dublin
Ireland
Millrock
United-kingdom-general
United-kingdom
France
Italy
Berkshire
Spain

Products recommended by biopharmaceutical scientists

Find out which lab products scientists are using to advance the field and what their experiences have been

Alberto-abarquero-zorrilla
Emma-king-lund
Agilent-technologies
Editorial-article
Automated-cell-counterby-logos
Marta-de-almeida
Lucie-bouquet
Triart-bioby
Multimode-microplate-reader
Cyte-flow-cytometer
Lei-zhang
Novocyte-benchtop-flow-cytometer

CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY

Please disregard the headline "Gilead Sciences Proposed to Acquire CymaBay for $32.50 Per Shr in Cash or a Total Equity Value of $4.3B," at 4:46 p.m. ET. The.

Gilead-sciences-proposed-to-acquire-cymabay
Sciences-proposed
Acquire-cymabay
Total-equity-value
Article-normal
Biotechnology-services
Pharmaceuticals
Healthcare-life-sciences
Biopharmaceuticals
Synd
Cymabay-therapeutics

Viking Therapeutics offers new shares after stock soars

Viking Therapeutics has a stock offering starting at $85 a discount from its Wednesday closing price of $94.50.

Novo-nordisk-wegovy
Jason-mccarthy
Akash-tewaria
Lilly-mounjaro
Naz-rahman
Eli-lilly-co
Therapeutics-inc
Viking-therapeutics-inc
Eli-lilly
Novo-nordisk
Article-normal
Biotechnology

vimarsana © 2020. All Rights Reserved.